Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
- Creator: Iland, Harry J. , Collins, Marnie , Hugman, Amanda , Reynolds, John , Di Iulio, Juliana , Tiley, Campbell , Taylor, Kerry , Filshie, Robin , Seldon, Michael , Taper, John , Szer, Jeff , Moore, John , Bradstock, Ken , Bashford, John , Seymour, John F. , Supple, Shane G. , Catalano, Alberto , Hertzberg, Mark , Browett, Peter , Grigg, Andrew , Firkin, Frank , Campbell, Lynda J.
- Resource Type: journal article
- Date: 2015
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
- Creator: Iland, Harry J. , Bradstock, Ken , Reynolds, John , Di Iulio, Juliana , Tiley, Campbell , Taylor, Kerry , Filshie, Robin , Seldon, Michael , Taper, John , Szer, Jeff , Moore, John , Bashford, John , Supple, Shane G. , Seymour, John F. , Catalano, Alberto , Collins, Marnie , Hertzberg, Mark , Browett, Peter , Grigg, Andrew , Firkin, Frank , Hugman, Amanda
- Resource Type: journal article
- Date: 2012